The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
Indian Journal of Postgraduate Dermatology · 30.06.2026 · 4 · 238-239
DOI: 10.25259/ijpgd_245_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Postgraduate Dermatology, online erschienen am 30.06.2026. Verfasst von Anuja Yadav und 3 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yadav, A., Sharma, A., Singh, N., & Garg, S. (2026). The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker. Indian Journal of Postgraduate Dermatology, 4, 238-239. https://doi.org/10.25259/ijpgd_245_2025
Vancouver
Yadav A, Sharma A, Singh N, Garg S. The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker. Indian Journal of Postgraduate Dermatology. 2026;4:238-239. doi:10.25259/ijpgd_245_2025
BibTeX
@article{Yadav2026,
author = {Yadav, Anuja and Sharma, Ankur and Singh, Niharika and Garg, Sonika},
title = {The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker},
journal = {Indian Journal of Postgraduate Dermatology},
year = {2026},
volume = {4},
pages = {238--239},
doi = {10.25259/ijpgd_245_2025}
}
EUVIMED